Limitations of spontaneous reperfusion and conventional medical therapy to afford myocardial protection through antecedent angina pectoris in acute myocardial infarction
Despite the cardioprotective effect of rapid coronary reperfusion, the effects of spontaneous recanalization on myocardial viability and metabolism are unknown. We studied whether preinfarction angina affords cardioprotection when spontaneous coronary reperfusion occurred in acute infarct patients. Myocardial tomographies with thallium and I-123-labeled-β-methyl-p-iodophenyl penta-decanoic acid (BMIPP) were performed in 27 acute myocardial infarct patients treated medically: 15 patients had preexisting angina before infarction (group A) and 12 did not (group B). Thallium and BMIPP abnormalities and regional function were quantified by a polar map and contrast ventriculography, respectively. There was no significant difference between thallium and BMIPP in the severity index in groups A and B (89 ± 97 vs. 85 ± 68, 97 ± 28 vs. 95 ± 27, respectively), and no significant difference between the groups in the thallium or BMIPP severity index. The ratio of the thallium severity index to that of BMIPP and the regional wall-motion abnormality index were identical in groups A and B. Both patient groups were divided into 2 subgroups based on the presence or absence of spontaneous coronary reperfusion: subgroups A1 and A2, and subgroups B1 and B2, respectively. There were no significant differences among the 4 subgroups in severity indexes for both tracers, the thallium/BMIPP ratio, or the asynergy score. The BMIPP severity index correlated significantly with that of thallium in all subgroups, but no significant difference between the regression lines was found. It is therefore unlikely that spontaneous coronary recanalization affords beneficial effects through preservation of myocardial viability in an ischemia-related zone, suggesting that the cardioprotective effect of preinfarction angina is a limited phenomenon in patients undergoing rapid coronary reperfusion.
Key wordsfatty acid metabolism pre-infarction angina cardioprotection spontaneous coronary recanalization
Unable to display preview. Download preview PDF.
- 11.Nakagawa Y, Ito H, Kitakaze M, Kusuoka H, Hori M, Kuzuya T, et al. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardiai infarction: Retrospective clinical evidence of “preconditioning.”J Am Coll Cardiol 25: 1076–1083, 1995.PubMedCrossRefGoogle Scholar
- 16.Nakata T, Hashimoto A, Miyamoto K, Fujimori K, Shogase T, Hirasawa K, et al. Clinical implications of mismatched uptakes of beta-methyl fatty acid analogue and thallium in infarcted myocardium: Correlations with coronary stenosis and regional wall motion abnormality.KAKU IGAKU (Jpn J Nucl Med) 32: 1061–1071, 1995.Google Scholar
- 19.Haq A, Morgan CD, Wilson RF, Daly PA, Baigrie RS, White CW, et al. Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group.Am J Cardiol 12: 379–383, 1993.CrossRefGoogle Scholar
- 22.Hashimoto A, Nakata T, Nagao K, Kobayashi H, Hase M, Yoshioka N, et al. Prediction of left ventricular functional recovery in patients with acute myocardial infarction using SPECT with thallium and beta-methyliodophenyl pentadecanoic acid.J Cardiol 26: 35–44, 1995.Google Scholar
- 24.Hase M, Nakata T, Yonekura S, Tsuchihashi K, Kobayashi H, Nagao K, et al. Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: Assessment by dual-isotope SPECT with thallium-201 and iodine-123 β-methyl fatty acid analogue.KAKU IGAKU (Jpn J Nucl Med) 30: 529–539, 1993.Google Scholar
- 26.Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog.J Nucl Med 33: 659–667, 1992.PubMedGoogle Scholar
- 29.Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina.J Nucl Med 36: 15934–15940, 1995.Google Scholar
- 32.Kloner RA, Shook T, Antman EA, Cannon CP, Przyklenk K, McCabe CH, et al. A prospective analysis on the potential preconditioning effect of preinfarct angina in TIMI 9.Circulation (Suppl) 94: 1–611, 1996. (abstract)Google Scholar
- 34.Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3(R,S)methylpentadecanoic acid (BMIPP), in relation to ATP concentration.J Nucl Med 31: 1818–1822, 1990.PubMedGoogle Scholar